Krystal Biotech (KRYS) PT Raised to $395 at Evercore ISI

June 26, 2026 8:26 AM

Evercore ISI analyst Josh Schimmer raised the price target on Krystal Biotech (NASDAQ: KRYS) to $395.00 (from $300.00) while maintaining a Outperform rating.

No results found